TZG Press Release Archives
April 2012
Expansion of Prior Authorization Policies for Oncology Agents
New Control Techniques on the Horizon for Payer Oncology Management
March 2012
Payer Management of Immunoglobulin Agents Intensifies
January 2012
Cost Concerns Continue to Dominate Benefit Design
Cost-Sharing and Prior Authorization Rates Differ between the Medical and Pharmacy Benefit
December 2011
Oncology Management for Soft Tumors Ramps Up
November 2011
Competitive Messaging in the Hepatitis C Market
October 2011
As Plavix's Patent Expiration Looms, Manufacturers Respond with New Products of Their Own
Uptake Uncertain for New, Unique COPD Agent Daliresp, Spiriva Marketing Strategy Adjusts
September 2011
Payers Look to Tighten Oncology Management through Quantity Limits and Clinical Pathways
September 2011
Evolution of Payer Management of Multiple Sclerosis
Contracting Discussions Increase in Rheumatoid Arthritis Market
August 2011
Payers and Employers Look for Ways to Offset Cost Increases Due to Health Care Reform
July 2011
Payers Anticipate Entry of Biosimilars; Plan to Offset Manufacturer Coupons
Dramatic Changes in Payer Management of Rheumatoid Arthritis
June 2011
New Entrants in the Hepatitis C Market Renew Payer Interest
May 2011
Price Tags for New Prostate Cancer Therapies Spark Payer Action
March 2011
Payers Look for Ways to Minimize Excess Costs in Cancer Care
March 2010
January 2010
Employers are Looking to Reduce Near-term Health Care Spending
January 2010
Payers Approach Specialty Categories with Multiple Management Priorities
July 2009
Employers Forced to Jeopardize Longer-term Outcomes to Secure Short-term Savings
March 2009
Payer Oncology Management Aspirations are Becoming Management Opportunities
September 2008
July 2008TZG announces the release of the eleventh edition of the Managed Care Injectables Index
June 2008TZG announces the release of the first Managed Care Benefit Design Index
October 2006TZG announces new syndicated tactics: The P&T Perspective Meeting (PTP)